Clinical trial
Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic…
NCT00209690 · Hokkaido Gastrointestinal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00209690 |
|---|---|
| Title | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. |
| Official title | Phase I/II Study of Docetaxel, Cisplatin and 5-fluorouracil(TPF) as 1st-line Chemotherapy in Patients With Metastatic Esophageal Cancer. |
| Lead sponsor | Hokkaido Gastrointestinal Cancer Study Group, Other |
| Collaborators | Hokkaido University Hospital |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | Taxotere, 5-FU, Briplatin |
| Enrollment | 30 |
| Start date | Oct 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | May 26, 2010 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: